Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Adaptive Biotechnologies Corp (ADPT)

Adaptive Biotechnologies Corp (ADPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Adaptive Biotechnologies Corp 1165 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98109 USA

P: 206-659-0067 F: 206-659-0667

Description:

Adaptive Biotechnologies Corporation is a commercial-stage biotech company. It develops and commercializes immune-driven clinical products to transform the diagnosis and treatment of disease. The company's product pipeline includes immunoSEQ, clonoSEQ and cellular therapy which are in clinical stage. Adaptive Biotechnologies Corporation is based in Seattle, Washington.

Key Statistics

Overview:

Market Capitalization, $K 1,017,256
Enterprise Value, $K 664,186
Shares Outstanding, K 142,873
Annual Sales, $ 154,340 K
Annual Net Income, $ -207,280 K
Last Quarter Sales, $ 43,660 K
Last Quarter Net Income, $ -52,050 K
60-Month Beta 0.96
% of Insider Shareholders 4.20%
% of Institutional Shareholders 93.49%
Float, K 136,872
% Float 95.80%
Short Volume Ratio 0.57

Growth:

1-Year Return -79.05%
3-Year Return -77.50%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.37 on 08/03/22
Next Earnings Date 11/02/22
Earnings Per Share ttm -1.64
EPS Growth vs. Prev Qtr 15.91%
EPS Growth vs. Prev Year -5.71%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ADPT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -39.90%
Return-on-Assets % -25.93%
Profit Margin % -134.30
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 6.34
Price/Cash Flow N/A
Price/Book 1.96
Book Value/Share 3.63
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar